Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 453

1.

Efficacy of Rituximab in a Patient With Partial Clinical Remission and Persistent Circulating PLA2R-Ab.

Georges E, Johanet C, Plaisier E, Debiec H, Ronco P, Dahan K.

Kidney Int Rep. 2019 Mar 13;4(7):1027-1030. doi: 10.1016/j.ekir.2019.03.002. eCollection 2019 Jul. No abstract available.

2.

Prevalence of tubulopathy and association with renal function loss in HIV-infected patients.

Lescure FX, Fellahi S, Pialoux G, Bastard JP, Eme AL, Esteve E, Lebrette MG, Guiard-Schmid JB, Capeau J, Ronco P, Costagliola D, Plaisier E.

Nephrol Dial Transplant. 2019 May 9. pii: gfz081. doi: 10.1093/ndt/gfz081. [Epub ahead of print]

PMID:
31071216
3.

Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.

Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM, Specks U, Fervenza FC, Ronco P.

J Am Soc Nephrol. 2019 Jun;30(6):1123-1136. doi: 10.1681/ASN.2018080852. Epub 2019 May 6.

PMID:
31061139
4.

Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.

Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A, Pontoizeau C, Cochat P, Bataille P, Bridoux F, Brignon P, Choquenet C, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Frimat M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M; French Cystinuria Group.

BJU Int. 2019 Feb 24. doi: 10.1111/bju.14721. [Epub ahead of print]

PMID:
30801923
5.

Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.

Zaghrini C, Seitz-Polski B, Justino J, Dolla G, Payré C, Jourde-Chiche N, Van de Logt AE, Booth C, Rigby E, Lonnbro-Widgren J, Nystrom J, Mariat C, Cui Z, Wetzels JFM, Ghiggeri G, Beck LH Jr, Ronco P, Debiec H, Lambeau G.

Kidney Int. 2019 Mar;95(3):666-679. doi: 10.1016/j.kint.2018.10.024.

PMID:
30784662
6.

Citius, altius, fortius . . . . faster, higher, stronger.

Ronco P, Rovin B; Associate Editors; Entire Editorial Team.

Kidney Int. 2019 Mar;95(3):476-478. doi: 10.1016/j.kint.2019.01.001. No abstract available.

PMID:
30784651
7.

Aside from acute renal failure cases, are urinary markers of glomerular and tubular function useful in clinical practice?

Bastard JP, Fellahi S, Regeniter A, Capeau J, Ronco P, Plaisier E.

Clin Biochem. 2019 Mar;65:1-6. doi: 10.1016/j.clinbiochem.2019.01.006. Epub 2019 Jan 25. Review.

PMID:
30685208
8.

Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.

Dahan K, Johannet C, Esteve E, Plaisier E, Debiec H, Ronco P.

Kidney Int. 2019 Jan;95(1):233-234. doi: 10.1016/j.kint.2018.08.045. No abstract available.

PMID:
30606419
9.

Factor H Autoantibodies and Membranous Nephropathy.

Seikrit C, Ronco P, Debiec H.

N Engl J Med. 2018 Dec 20;379(25):2479-2481. doi: 10.1056/NEJMc1805857. No abstract available.

PMID:
30575481
10.

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.

Chauvet S, Roumenina LT, Aucouturier P, Marinozzi MC, Dragon-Durey MA, Karras A, Delmas Y, Le Quintrec M, Guerrot D, Jourde-Chiche N, Ribes D, Ronco P, Bridoux F, Fremeaux-Bacchi V.

Front Immunol. 2018 Oct 2;9:2260. doi: 10.3389/fimmu.2018.02260. eCollection 2018.

11.

Conservative three-quarter versus subtotal seven-eighths parathyroidectomy in secondary hyperparathyroidism.

Veyrat M, Fessi H, Haymann JP, Ronco P, Lacau St Guily J, Périé S.

Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Apr;136(2):63-68. doi: 10.1016/j.anorl.2018.09.003. Epub 2018 Oct 13.

PMID:
30327179
12.

The authors reply.

van de Logt AE, Dahan K, Ronco P, Wetzels J.

Kidney Int. 2018 Oct;94(4):830. doi: 10.1016/j.kint.2018.06.018. No abstract available.

PMID:
30243321
13.

Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation.

Sethi S, Dasari S, Plaisier E, Ronco P, Nasr SH, Brocheriou I, Theis JD, Vrana JA, Zimmermann MT, Quint PS, McPhail ED, Kurtin PJ.

Kidney Int Rep. 2018 Apr 22;3(5):1193-1201. doi: 10.1016/j.ekir.2018.04.009. eCollection 2018 Sep.

14.

HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy.

Wang HY, Cui Z, Xie LJ, Zhang LJ, Pei ZY, Chen FJ, Qu Z, Huang J, Zhang YM, Wang X, Wang F, Meng LQ, Cheng XY, Liu G, Zhou XJ, Zhang H, Debiec H, Ronco P, Zhao MH.

Kidney Int. 2018 Nov;94(5):974-982. doi: 10.1016/j.kint.2018.06.005. Epub 2018 Aug 30.

PMID:
30173899
15.

The Bowman's shield: a tribute to translational science and Detlef Schlöndorff.

Harris D, Wyatt CM, Fogo AB, Ronco P.

Kidney Int. 2018 Sep;94(3):448-450. doi: 10.1016/j.kint.2018.07.001. Epub 2018 Jul 10. No abstract available.

PMID:
30006006
16.

Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.

Debiec H, Dossier C, Letouzé E, Gillies CE, Vivarelli M, Putler RK, Ars E, Jacqz-Aigrain E, Elie V, Colucci M, Debette S, Amouyel P, Elalaoui SC, Sefiani A, Dubois V, Simon T, Kretzler M, Ballarin J, Emma F, Sampson MG, Deschênes G, Ronco P.

J Am Soc Nephrol. 2018 Jul;29(7):2000-2013. doi: 10.1681/ASN.2017111185. Epub 2018 Jun 14.

17.

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy.

Dahan K, Gillion V, Johanet C, Debiec H, Ronco P.

Kidney Int Rep. 2017 Nov 3;3(2):498-501. doi: 10.1016/j.ekir.2017.10.013. eCollection 2018 Mar. No abstract available.

18.

Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy.

Berchtold L, Zanetta G, Dahan K, Mihout F, Peltier J, Guerrot D, Brochériou I, Ronco P, Debiec H.

Kidney Int Rep. 2017 Sep 21;3(2):486-491. doi: 10.1016/j.ekir.2017.09.009. eCollection 2018 Mar. No abstract available.

19.

Gabriel Richet: when medicine combines with courage.

Ronco P.

BMC Nephrol. 2018 Apr 19;19(1):92. doi: 10.1186/s12882-018-0887-4.

20.

Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.

van de Logt AE, Dahan K, Rousseau A, van der Molen R, Debiec H, Ronco P, Wetzels J.

Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019. No abstract available.

PMID:
29571438
21.

Primary glomerular nephropathy among hospitalized patients in a national database in China.

Li J, Cui Z, Long J, Huang W, Wang J, Zhang H, Wang H, Zhang L, Ronco P, Zhao MH.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2173-2181. doi: 10.1093/ndt/gfy022.

PMID:
29509919
22.

Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.

Dinh A, Fessi H, Duran C, Batista R, Michelon H, Bouchand F, Lepeule R, Vittecoq D, Escaut L, Sobhani I, Lawrence C, Chast F, Ronco P, Davido B.

J Hosp Infect. 2018 Aug;99(4):481-486. doi: 10.1016/j.jhin.2018.02.018. Epub 2018 Mar 2.

PMID:
29477634
23.

Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells.

Oba-Yabana I, Mori T, Takahashi C, Hirose T, Ohsaki Y, Kinugasa S, Muroya Y, Sato E, Nguyen G, Piedagnel R, Ronco PM, Totsune K, Ito S.

Sci Rep. 2018 Feb 8;8(1):2648. doi: 10.1038/s41598-018-20940-x.

24.

Membranal and Blood-Soluble HLA Class II Peptidome Analyses Using Data-Dependent and Independent Acquisition.

Ritz D, Sani E, Debiec H, Ronco P, Neri D, Fugmann T.

Proteomics. 2018 Jun;18(12):e1700246. doi: 10.1002/pmic.201700246. Epub 2018 Mar 14.

25.

Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.

Cez A, Brocheriou I, Lescure FX, Adam C, Girard PM, Pialoux G, Moestrup SK, Fellahi S, Bastard JP, Ronco P, Plaisier E.

Hum Pathol. 2018 Mar;73:89-101. doi: 10.1016/j.humpath.2017.12.018. Epub 2018 Jan 5.

PMID:
29309806
26.

Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.

Seitz-Polski B, Debiec H, Rousseau A, Dahan K, Zaghrini C, Payré C, Esnault VLM, Lambeau G, Ronco P.

J Am Soc Nephrol. 2018 Feb;29(2):401-408. doi: 10.1681/ASN.2017070734. Epub 2017 Nov 7.

27.

Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome.

Dorval G, Gribouval O, Martinez-Barquero V, Machuca E, Tête MJ, Baudouin V, Benoit S, Chabchoub I, Champion G, Chauveau D, Chehade H, Chouchane C, Cloarec S, Cochat P, Dahan K, Dantal J, Delmas Y, Deschênes G, Dolhem P, Durand D, Ekinci Z, El Karoui K, Fischbach M, Grunfeld JP, Guigonis V, Hachicha M, Hogan J, Hourmant M, Hummel A, Kamar N, Krummel T, Lacombe D, Llanas B, Mesnard L, Mohsin N, Niaudet P, Nivet H, Parvex P, Pietrement C, de Pontual L, Noble CP, Ribes D, Ronco P, Rondeau E, Sallee M, Tsimaratos M, Ulinski T, Salomon R, Antignac C, Boyer O.

Pediatr Nephrol. 2018 Mar;33(3):473-483. doi: 10.1007/s00467-017-3819-9. Epub 2017 Oct 23.

PMID:
29058154
28.

Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study.

Jachiet V, Mekinian A, Carrat F, Grignano E, Retbi A, Boffa JJ, Ronco P, Rondeau E, Sellam J, Berenbaum F, Chazouillères O, Capron J, Alamowitch S, Chasset F, Frances C, Coppo P, Fain O; French Network of systemic and immune disorders associated with hemopathies and cancer (MINHEMON).

Leuk Lymphoma. 2018 Jun;59(6):1399-1405. doi: 10.1080/10428194.2017.1379075. Epub 2017 Oct 3.

PMID:
28972423
29.

Physical water scarcity metrics for monitoring progress towards SDG target 6.4: An evaluation of indicator 6.4.2 "Level of water stress".

Vanham D, Hoekstra AY, Wada Y, Bouraoui F, de Roo A, Mekonnen MM, van de Bund WJ, Batelaan O, Pavelic P, Bastiaanssen WGM, Kummu M, Rockström J, Liu J, Bisselink B, Ronco P, Pistocchi A, Bidoglio G.

Sci Total Environ. 2018 Feb 1;613-614:218-232. doi: 10.1016/j.scitotenv.2017.09.056. Epub 2017 Sep 12. Review.

30.

Flyscan opportunities in medicine: the case of quantum rattle based on gold quantum dots.

Esteve E, Reguer S, Boissiere C, Chanéac C, Lugo G, Jouanneau C, Mocuta C, Thiaudière D, Leclercq N, Leyh B, Greisch JF, Berthault J, Daudon M, Ronco P, Bazin D.

J Synchrotron Radiat. 2017 Sep 1;24(Pt 5):991-999. doi: 10.1107/S1600577517009572. Epub 2017 Aug 7.

PMID:
28862621
31.

Membranous Nephropathy and Intrarenal Extramedullary Hematopoiesis in a Patient With Myelofibrosis.

Philipponnet C, Ronco P, Aniort J, Kemeny JL, Heng AE.

Am J Kidney Dis. 2017 Dec;70(6):874-877. doi: 10.1053/j.ajkd.2017.06.022. Epub 2017 Aug 16.

PMID:
28821362
32.

Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.

Wang J, Cui Z, Lu J, Probst C, Zhang YM, Wang X, Qu Z, Wang F, Meng LQ, Cheng XY, Liu G, Debiec H, Ronco P, Zhao MH.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1642-1651. doi: 10.2215/CJN.01460217. Epub 2017 Aug 11.

33.

A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.

Ronco P, Debiec H.

Pflugers Arch. 2017 Aug;469(7-8):997-1005. doi: 10.1007/s00424-017-2007-x. Epub 2017 Jun 8. Review.

PMID:
28597189
34.

Interest of the combined measurement of selected urinary proteins in the diagnosis approach in nephrology.

Bastard JP, Fellahi S, Lescure FX, Capeau J, Ronco P, Plaisier E.

Ann Biol Clin (Paris). 2017 Jun 1;75(3):327-333. doi: 10.1684/abc.2017.1247.

PMID:
28540855
35.

B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab.

Rosenzwajg M, Languille E, Debiec H, Hygino J, Dahan K, Simon T, Klatzmann D, Ronco P.

Kidney Int. 2017 Jul;92(1):227-237. doi: 10.1016/j.kint.2017.01.012. Epub 2017 Mar 15.

PMID:
28318628
36.

A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

Sethi S, D'Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, Glassock RJ, Fervenza FC, Seshan SV, Rule A, Racusen LC, Radhakrishnan J, Winearls CG, Appel GB, Bajema IM, Chang A, Colvin RB, Cook HT, Hariharan S, Herrera Hernandez LP, Kambham N, Mengel M, Nath KA, Rennke HG, Ronco P, Rovin BH, Haas M.

Kidney Int. 2017 Apr;91(4):787-789. doi: 10.1016/j.kint.2017.01.002.

PMID:
28314581
37.

Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.

Pourcine F, Dahan K, Mihout F, Cachanado M, Brocheriou I, Debiec H, Ronco P.

PLoS One. 2017 Mar 3;12(3):e0173201. doi: 10.1371/journal.pone.0173201. eCollection 2017.

38.

Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomics.

Gilquin B, Louwagie M, Jaquinod M, Cez A, Picard G, El Kholy L, Surin B, Garin J, Ferro M, Kofman T, Barau C, Plaisier E, Ronco P, Brun V.

Talanta. 2017 Mar 1;164:77-84. doi: 10.1016/j.talanta.2016.11.023. Epub 2016 Nov 13.

PMID:
28107998
39.

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

Chauvet S, Frémeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, François A, Le Quintrec M, Javaugue V, Ribes D, Vrigneaud L, Arnulf B, Goujon JM, Ronco P, Touchard G, Bridoux F.

Blood. 2017 Mar 16;129(11):1437-1447. doi: 10.1182/blood-2016-08-737163. Epub 2017 Jan 9.

40.

Col4a1 mutation generates vascular abnormalities correlated with neuronal damage in a mouse model of HANAC syndrome.

Trouillet A, Lorach H, Dubus E, El Mathari B, Ivkovic I, Dégardin J, Simonutti M, Paques M, Guillonneau X, Sennlaub F, Sahel JA, Ronco P, Plaisier E, Picaud S.

Neurobiol Dis. 2017 Apr;100:52-61. doi: 10.1016/j.nbd.2016.12.014. Epub 2017 Jan 3.

PMID:
28057519
41.

HANAC Col4a1 Mutation in Mice Leads to Skeletal Muscle Alterations due to a Primary Vascular Defect.

Guiraud S, Migeon T, Ferry A, Chen Z, Ouchelouche S, Verpont MC, Sado Y, Allamand V, Ronco P, Plaisier E.

Am J Pathol. 2017 Mar;187(3):505-516. doi: 10.1016/j.ajpath.2016.10.020. Epub 2017 Jan 3.

42.

A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.

Jasiek M, Karras A, Le Guern V, Krastinova E, Mesbah R, Faguer S, Jourde-Chiche N, Fauchais AL, Chiche L, Dernis E, Moulis G, Fraison JB, Lazaro E, Jullien P, Hachulla E, Le Quellec A, Rémy P, Hummel A, Costedoat-Chalumeau N, Ronco P, Vanhille P, Meas-Yedid V, Cordonnier C, Ferlicot S, Daniel L, Seror R, Mariette X, Thervet E, François H, Terrier B.

Rheumatology (Oxford). 2017 Mar 1;56(3):362-370. doi: 10.1093/rheumatology/kew376.

43.

MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.

Cui Z, Xie LJ, Chen FJ, Pei ZY, Zhang LJ, Qu Z, Huang J, Gu QH, Zhang YM, Wang X, Wang F, Meng LQ, Liu G, Zhou XJ, Zhu L, Lv JC, Liu F, Zhang H, Liao YH, Lai LH, Ronco P, Zhao MH.

J Am Soc Nephrol. 2017 May;28(5):1651-1664. doi: 10.1681/ASN.2016020114. Epub 2016 Nov 16.

44.

COL4A1-Related Disorders.

Plaisier E, Ronco P.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2009 Jun 25 [updated 2016 Jul 7].

45.

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.

Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group.

J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27.

46.

Extracorporeal shock wave therapy does not improve hypertensive nephropathy.

Caron J, Michel PA, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Physiol Rep. 2016 Jun;4(11). pii: e12699. doi: 10.14814/phy2.12699.

47.

Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.

Guerry MJ, Vanhille P, Ronco P, Debiec H.

Kidney Int. 2016 Jun;89(6):1399. doi: 10.1016/j.kint.2015.11.032. No abstract available.

PMID:
27181779
48.

Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency.

Bally S, Debiec H, Ponard D, Dijoud F, Rendu J, Fauré J, Ronco P, Dumestre-Perard C.

J Am Soc Nephrol. 2016 Dec;27(12):3539-3544. Epub 2016 May 6.

49.

Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.

Okpechi IG, Ameh OI, Bello AK, Ronco P, Swanepoel CR, Kengne AP.

PLoS One. 2016 Mar 24;11(3):e0152203. doi: 10.1371/journal.pone.0152203. eCollection 2016.

50.

Gabriel Richet: the Man and the Scientist.

Ardaillou R, Ronco P.

G Ital Nefrol. 2016 Feb;33 Suppl 66:33.S66.7.

Supplemental Content

Support Center